The traveler’s diarrhea market is primarily propelled by the increasing instances of viral, bacterial, and parasitic infections due to inadequate public hygiene, leading to food and water contamination.
Scleroderma Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The increasing cases of autoimmune disorders, which cause inflammation and excess collagen production in the affected cells, thereby leading to damage as well as scarring, are primarily augmenting the scleroderma market.
Hepatitis C Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The growing utilization of injection drugs, which involves the use of needle and syringe sharing that can lead to the risk of virus transmission, is primarily driving the hepatitis C market.
Chronic Hepatitis B Market 2023: Epidemiology, Industry Trends, Size, Share A...frankmorgan27
The chronic hepatitis B market is primarily driven by the increasing incidence of high-risk behaviors such as unprotected sexual intercourse with an infected partner, sharing needles or other drug paraphernalia, and exposure to infected blood or body fluids.
Overactive Bladder Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The rising cases of urinary tract infections, which lead to overactivity of the detrusor urinae muscle and involuntary contractions in the bladder, are primarily driving the overactive bladder market.
Bulimia Nervosa Market 2023: Epidemiology, Industry Trends, Size, Share And F...frankmorgan27
The elevating cases of abnormalities in brain chemistry or neurotransmitter systems, including the serotonin system, are primarily stimulating the bulimia nervosa market.
Chronic Cough Market 2023: Epidemiology, Industry Trends, Size, Share And For...frankmorgan27
The growing cases of respiratory infections owing to high levels of air pollution, prolonged exposure to dust and chemical fumes, chain smoking, etc., are primarily driving the chronic cough market.
Keratitis Market 2023: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The rising incidences of bacterial, viral, fungal, or parasitic infections — where the cornea is directly invaded by microorganisms causing damage and inflammation are primarily fueling the growth of the keratitis market.
Scleroderma Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The increasing cases of autoimmune disorders, which cause inflammation and excess collagen production in the affected cells, thereby leading to damage as well as scarring, are primarily augmenting the scleroderma market.
Hepatitis C Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The growing utilization of injection drugs, which involves the use of needle and syringe sharing that can lead to the risk of virus transmission, is primarily driving the hepatitis C market.
Chronic Hepatitis B Market 2023: Epidemiology, Industry Trends, Size, Share A...frankmorgan27
The chronic hepatitis B market is primarily driven by the increasing incidence of high-risk behaviors such as unprotected sexual intercourse with an infected partner, sharing needles or other drug paraphernalia, and exposure to infected blood or body fluids.
Overactive Bladder Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The rising cases of urinary tract infections, which lead to overactivity of the detrusor urinae muscle and involuntary contractions in the bladder, are primarily driving the overactive bladder market.
Bulimia Nervosa Market 2023: Epidemiology, Industry Trends, Size, Share And F...frankmorgan27
The elevating cases of abnormalities in brain chemistry or neurotransmitter systems, including the serotonin system, are primarily stimulating the bulimia nervosa market.
Chronic Cough Market 2023: Epidemiology, Industry Trends, Size, Share And For...frankmorgan27
The growing cases of respiratory infections owing to high levels of air pollution, prolonged exposure to dust and chemical fumes, chain smoking, etc., are primarily driving the chronic cough market.
Keratitis Market 2023: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The rising incidences of bacterial, viral, fungal, or parasitic infections — where the cornea is directly invaded by microorganisms causing damage and inflammation are primarily fueling the growth of the keratitis market.
Pneumonia Market 2023: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The pneumonia market is witnessing significant growth due to the rising cases of HIV/AIDS and cancer, which compromise immune systems and increase susceptibility to infections.
Colorectal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And...frankmorgan27
The increasing occurrences of polyps and inflammatory bowel conditions like ulcerative colitis or Crohn’s disease are primarily propelling the colorectal cancer market.
Chronic Bronchitis Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The primary driver of the chronic bronchitis market is the rising occurrence of mutations in the dystrophin gene, disrupting essential structural and signaling functions within muscle cells.
Fibromyalgia Market 2023: Epidemiology, Industry Trends, Size, Share And Fore...frankmorgan27
The fibromyalgia market is primarily driven by the increasing prevalence of various triggering factors, including neurotransmitter imbalances, exposure to toxins, and infections such as Lyme disease, Hepatitis C, and physical or emotional trauma.
Leiomyosarcoma Market 2023: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The elevating cases of certain genetic conditions, such as renal cell cancer (HLRCC) syndrome and hereditary leiomyomatosis, which is characterized by the development of leiomyomas, are primarily augmenting the leiomyosarcoma market.
Malignant Pleural Mesothelioma Market 2023: Epidemiology, Industry Trends, Si...frankmorgan27
The elevating cases of exposure to asbestos fibers, which become lodged in the lining of the abdomen, lungs, or heart, and cause irritation and inflammation, are primarily augmenting the malignant pleural mesothelioma market.
Chronic Refractory Cough Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The growing cases of respiratory tract disorders secondary to sensory nerve damage caused by viral infections and inflammation are primarily augmenting the chronic refractory cough market.
Menkes Disease Market 2023: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The elevating cases of X-linked genetic disorders resulting from a non-working gene on the X chromosome are primarily augmenting the Menkes disease market.
Febrile Neutropenia Market 2023: Epidemiology, Industry Trends, Size, Share A...frankmorgan27
The growing utilization of chemotherapy or radiation therapy, which can hinder the bone marrow’s ability to produce new blood cells, is primarily driving the febrile neutropenia market.
Cervical Dystonia Market 2023: Epidemiology, Industry Trends, Size, Share And...frankmorgan27
The elevating prevalence of neurological disorders, which cause abnormalities in the basal ganglia or other brain areas that control body movement, is primarily augmenting the cervical dystonia market.
Meningitis Market 2023: Epidemiology, Industry Trends, Size, Share And Foreca...frankmorgan27
The rise in the proliferation of pathogens, including bacteria, viruses, fungi, and parasites that infiltrate the body via the nasal passage or bloodstream and migrate to the central nervous system is primarily driving the meningitis market growth.
Nutrigenomics Market by Product Type, Distribution Channel, End User 2024-2032IMARC Group
The global nutrigenomics market size reached US$ 1,212.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,049.7 Million by 2032, exhibiting a growth rate (CAGR) of 10.47% during 2024-2032.
More Info:- https://www.imarcgroup.com/nutrigenomics-market
Mesothelioma Market 2023: Epidemiology, Industry Trends, Size, Share And Fore...frankmorgan27
The growing instances of exposure to asbestos fibers, which become deposited in the lining of the lungs, abdomen, or heart, and lead to irritation and inflammation, are primarily augmenting the mesothelioma market.
Bronchopulmonary Dysplasia Market 2023: Epidemiology, Industry Trends, Size, ...frankmorgan27
The elevating cases of lung injury and inflammation caused by numerous risk factors, such as oxygen toxicity, mechanical ventilation, infections like pneumonia and sepsis, etc., are primarily augmenting the bronchopulmonary dysplasia market.
Vulvovaginal Candidiasis Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The increasing utilization of antibiotics, which leads to the loss of beneficial bacteria that keep the vaginal ecosystem balanced, is primarily driving the vulvovaginal candidiasis market.
Minimal Residual Disease Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The rising instances of hematologic malignancies and the inflating need to treat these conditions using radiotherapy and chemotherapy are primarily driving the minimal residual disease market.
Lymphedema Market 2023: Epidemiology, Industry Trends, Size, Share And Foreca...frankmorgan27
The elevating cases of infections and inflammatory diseases that damage the tissue around the vessels or lymph nodes are primarily augmenting the lymphedema market.
Hepatitis B Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The elevating cases of infections from the hepatitis B virus, which is spread through contact with infected blood or bodily fluids like semen and vaginal secretions, are primarily augmenting the hepatitis B market.
Pollen Allergy Market 2024: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The Pollen Allergy market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Pollen Allergy market.
Pneumonia Market 2024: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The Pneumonia market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Pneumonia market.
More Related Content
Similar to Traveler’s Diarrhea Market 2023: Epidemiology, Industry Trends, Size, Share And Forecast To 2033
Pneumonia Market 2023: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The pneumonia market is witnessing significant growth due to the rising cases of HIV/AIDS and cancer, which compromise immune systems and increase susceptibility to infections.
Colorectal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And...frankmorgan27
The increasing occurrences of polyps and inflammatory bowel conditions like ulcerative colitis or Crohn’s disease are primarily propelling the colorectal cancer market.
Chronic Bronchitis Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The primary driver of the chronic bronchitis market is the rising occurrence of mutations in the dystrophin gene, disrupting essential structural and signaling functions within muscle cells.
Fibromyalgia Market 2023: Epidemiology, Industry Trends, Size, Share And Fore...frankmorgan27
The fibromyalgia market is primarily driven by the increasing prevalence of various triggering factors, including neurotransmitter imbalances, exposure to toxins, and infections such as Lyme disease, Hepatitis C, and physical or emotional trauma.
Leiomyosarcoma Market 2023: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The elevating cases of certain genetic conditions, such as renal cell cancer (HLRCC) syndrome and hereditary leiomyomatosis, which is characterized by the development of leiomyomas, are primarily augmenting the leiomyosarcoma market.
Malignant Pleural Mesothelioma Market 2023: Epidemiology, Industry Trends, Si...frankmorgan27
The elevating cases of exposure to asbestos fibers, which become lodged in the lining of the abdomen, lungs, or heart, and cause irritation and inflammation, are primarily augmenting the malignant pleural mesothelioma market.
Chronic Refractory Cough Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The growing cases of respiratory tract disorders secondary to sensory nerve damage caused by viral infections and inflammation are primarily augmenting the chronic refractory cough market.
Menkes Disease Market 2023: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The elevating cases of X-linked genetic disorders resulting from a non-working gene on the X chromosome are primarily augmenting the Menkes disease market.
Febrile Neutropenia Market 2023: Epidemiology, Industry Trends, Size, Share A...frankmorgan27
The growing utilization of chemotherapy or radiation therapy, which can hinder the bone marrow’s ability to produce new blood cells, is primarily driving the febrile neutropenia market.
Cervical Dystonia Market 2023: Epidemiology, Industry Trends, Size, Share And...frankmorgan27
The elevating prevalence of neurological disorders, which cause abnormalities in the basal ganglia or other brain areas that control body movement, is primarily augmenting the cervical dystonia market.
Meningitis Market 2023: Epidemiology, Industry Trends, Size, Share And Foreca...frankmorgan27
The rise in the proliferation of pathogens, including bacteria, viruses, fungi, and parasites that infiltrate the body via the nasal passage or bloodstream and migrate to the central nervous system is primarily driving the meningitis market growth.
Nutrigenomics Market by Product Type, Distribution Channel, End User 2024-2032IMARC Group
The global nutrigenomics market size reached US$ 1,212.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,049.7 Million by 2032, exhibiting a growth rate (CAGR) of 10.47% during 2024-2032.
More Info:- https://www.imarcgroup.com/nutrigenomics-market
Mesothelioma Market 2023: Epidemiology, Industry Trends, Size, Share And Fore...frankmorgan27
The growing instances of exposure to asbestos fibers, which become deposited in the lining of the lungs, abdomen, or heart, and lead to irritation and inflammation, are primarily augmenting the mesothelioma market.
Bronchopulmonary Dysplasia Market 2023: Epidemiology, Industry Trends, Size, ...frankmorgan27
The elevating cases of lung injury and inflammation caused by numerous risk factors, such as oxygen toxicity, mechanical ventilation, infections like pneumonia and sepsis, etc., are primarily augmenting the bronchopulmonary dysplasia market.
Vulvovaginal Candidiasis Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The increasing utilization of antibiotics, which leads to the loss of beneficial bacteria that keep the vaginal ecosystem balanced, is primarily driving the vulvovaginal candidiasis market.
Minimal Residual Disease Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The rising instances of hematologic malignancies and the inflating need to treat these conditions using radiotherapy and chemotherapy are primarily driving the minimal residual disease market.
Lymphedema Market 2023: Epidemiology, Industry Trends, Size, Share And Foreca...frankmorgan27
The elevating cases of infections and inflammatory diseases that damage the tissue around the vessels or lymph nodes are primarily augmenting the lymphedema market.
Hepatitis B Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The elevating cases of infections from the hepatitis B virus, which is spread through contact with infected blood or bodily fluids like semen and vaginal secretions, are primarily augmenting the hepatitis B market.
Similar to Traveler’s Diarrhea Market 2023: Epidemiology, Industry Trends, Size, Share And Forecast To 2033 (20)
Pollen Allergy Market 2024: Epidemiology, Industry Trends, Size, Share And Fo...frankmorgan27
The Pollen Allergy market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Pollen Allergy market.
Pneumonia Market 2024: Epidemiology, Industry Trends, Size, Share And Forecas...frankmorgan27
The Pneumonia market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Pneumonia market.
Anal Cancer Market 2023: Epidemiology, Industry Trends, Size, Share And Forec...frankmorgan27
The Anal Cancer Market report thoroughly examines the market size, latest trends, and growth forecast. The report includes an overview of the disease and market scenario, as well as market trends, growth prospects, investment opportunities, and industry prospects. Additionally, it provides competitor analysis, regional analysis, and recent advancements in the Anal Cancer Market.
Sandhoff Disease Market 2023: Epidemiology, Industry Trends, Size, Share And ...frankmorgan27
The growing cases of lipid storage disorders owing to the inherited deficiencies in producing functional catabolic enzymes are primarily augmenting the Sandhoff disease market.
Turner Syndrome Market 2023: Epidemiology, Industry Trends, Size, Share And F...frankmorgan27
The elevating cases of structural abnormalities of the X chromosome, which disrupt the normal functioning of genes, are primarily augmenting the Turner syndrome market.
The increasing cases of upper motor neuron lesions, which can be caused by injury, some diseases, and conditions that may damage the central nervous system, are primarily augmenting the upper limb hypotonia market.
Nasal Polyps Market 2023: Epidemiology, Industry Trends, Size, Share And Fore...frankmorgan27
The nasal polyps market is growing due to an upsurge in allergies and infections, which cause chronic nasal inflammation. This is further exacerbated by increased occurrences of genetic mutations linked to the immune system, leading to abnormal mucus production in the nasal and sinus linings.
Bullous Pemphigoid Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The rising incidences of immune-mediated disorders that can cause inflammation owing to the overactivation of antibodies inside the body are primarily driving the bullous pemphigoid market.
Cutaneous T-Cell Lymphoma Market 2023: Epidemiology, Industry Trends, Size, S...frankmorgan27
The growing instances of immune system malfunctions that trigger the stimulation of T-cells are primarily driving the cutaneous T-cell lymphoma market.
Bunion Market 2023: Epidemiology, Industry Trends, Size, Share And Forecast T...frankmorgan27
The growing cases of excessive foot pronation, which increases the pressure on the toe and leads to deformation of the joint’s medial capsular structures, are primarily driving the bunion market.
Peripheral t cell Lymphoma Market 2023: Epidemiology, Industry Trends, Size, ...frankmorgan27
The peripheral T-cell lymphoma market is experiencing significant growth due to the rising prevalence of genetic mutations and chromosomal disorders causing uncontrolled lymphocyte proliferation.
Bronchitis Market 2023: Epidemiology, Industry Trends, Size, Share And Foreca...frankmorgan27
The rising cases of bacterial and viral infections, which can irritate the bronchial tubes and cause airway inflammation, are primarily augmenting the bronchitis market
Avascular Necrosis Market 2023: Epidemiology, Industry Trends, Size, Share An...frankmorgan27
The growing instances of bone injuries, such as broken bones and dislocated hips that can harm nearby blood vessels and disrupt the blood supply are primarily driving the avascular necrosis market.
Deep Vein Thrombosis Market 2023: Epidemiology, Industry Trends, Size, Share ...frankmorgan27
The growing instances of venous stasis on account of numerous causes, such as prolonged immobility, pregnancy, obesity, recent surgery, etc., are primarily driving the deep vein thrombosis market.
Surgical Site Infections Market 2023: Epidemiology, Industry Trends, Size, Sh...frankmorgan27
The growing instances of exogenous and endogenous infections caused by contamination of the operative site by microorganisms during the surgical procedure are primarily driving the surgical site infections market.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.
3. Report Description and Highlights
Traveler’s Diarrhea Market 2023-2033
The newly published report by IMARC Group, titled ”Traveler’s Diarrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity,
and Forecast 2023-2033″, presents a comprehensive analysis of the traveler’s diarrhea market size The report provides an overview of the
market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market
scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major
markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
What is traveler’s diarrhea market?
Traveler’s diarrhea refers to a digestive tract disorder that occurs from the consumption of contaminated food or water while traveling. It is
most commonly triggered by E. coli bacteria but can also originate from other pathogens like viruses and parasites. Symptoms often involve
abdominal cramps, nausea, vomiting, frequent watery bowel movements, bloating, loss of appetite, and an urgency to defecate. Severe cases
can manifest as dehydration, dry mouth, fatigue, weakness, bloody stools, headaches, dizziness, and electrolyte imbalances. The diagnosis of
traveler’s diarrhea relies on the patient’s symptoms and detailed travel history. A range of medical exams, stool cultures, and polymerase chain
reaction (PCR) tests are conducted to assess the individual’s health and exclude other potential diseases. 3
4. Report Description and Highlights
What are the key drivers and trends in the traveler’s diarrhea market?
The traveler’s diarrhea market is primarily propelled by the increasing instances of viral, bacterial, and parasitic infections due to
inadequate public hygiene, leading to food and water contamination. Rising cases of risk factors like young adult travelers, poor dietary
habits, and compromised immunity also contribute to market growth. The widespread use of antimotility agents such as loperamide and
diphenoxylate, which manage symptoms by controlling gastrointestinal muscle spasms and decreasing bowel movement frequency, acts as
another significant growth catalyst. The expanding application of lifestyle modifications like consuming bananas, rice, applesauce, and toast
(BRAT) diet, which assists in alleviating stomach distress and preventing dehydration, is further enhancing market growth. The rising
popularity of oral rehydration solutions, which optimize fluid absorption in the intestines and rapidly restore body electrolytes, is
anticipated to drive the traveler’s diarrhea market in future years.
Request a Sample Report: https://www.imarcgroup.com/travelers-diarrhea-market/requestsample
4
5. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
5
6. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Traveler’s Diarrhea market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Traveler’s Diarrhea market
• Reimbursement scenario in the market
• In-market and pipeline drugs
6
7. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/travelers-diarrhea-market
7
8. Key Questions Answered in the Report
1. How has the Traveler’s Diarrhea Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Traveler’s Diarrhea Market across the seven major markets in 2022 and what will it look like in
2033?
4. What is the growth rate of the Traveler’s Diarrhea Market across the seven major markets and what will be the expected growth over
the next ten years?
5. What are the key unmet needs in the market?
8
10. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
10
11. Table of Contents
4 Traveler’s Diarrhea - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Traveler’s Diarrhea - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/travelers-diarrhea-market/toc
11